Search Results

Amuvatinib 25 mg  | Purity Not Available

TargetMol

Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.

More Information Supplier Page

Amuvatinib 1 mg  | Purity Not Available

TargetMol

Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.

More Information Supplier Page

Dactolisib 200 mg  | 99.71%

TargetMol

Dactolisib is an orally bioavailable inhibitor of PI3K and mTOR (IC50s: 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR).

More Information Supplier Page

Dactolisib 100 mg  | 99.71%

TargetMol

Dactolisib is an orally bioavailable inhibitor of PI3K and mTOR (IC50s: 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR).

More Information Supplier Page